RNAZ
Transcode Therapeutics, Inc.Company with tickers: RNAZ
CIK
1829635
CUSIP
89357L501
Shares Outstanding
950,302
Investor Relations
https://ir.transcodetherapeutics.com/
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
47/100
Short interest 3.0% of shares — P60
Days to cover 1.9 — P40
Short-volume trend -3.0% — P41
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-05-29). Equal-weight mean of the available factors.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-05-29 | 28,142 | 36,265 | -8,123 | 1.87 |
| 2026-05-15 | 36,265 | 35,757 | +508 | 4.07 |
| 2026-04-30 | 35,757 | 41,071 | -5,314 | 7.56 |
| 2026-04-15 | 41,071 | 49,976 | -8,905 | 6.39 |
| 2026-03-31 | 49,976 | 68,334 | -18,358 | 6.09 |
| 2026-03-13 | 68,334 | 77,552 | -9,218 | 5.39 |
| 2026-02-27 | 77,552 | 113,877 | -36,325 | 4.48 |
| 2026-02-13 | 113,877 | 34,640 | +79,237 | 1.00 |
| 2026-01-30 | 34,640 | 59,701 | -25,061 | 1.61 |
| 2026-01-15 | 59,701 | 59,476 | +225 | 1.00 |
| 2025-12-31 | 59,476 | 41,544 | +17,932 | 1.68 |
| 2025-12-15 | 41,544 | 37,989 | +3,555 | 2.55 |
| 2025-11-28 | 37,989 | 35,717 | +2,272 | 4.92 |
| 2025-11-14 | 35,717 | 27,054 | +8,663 | 2.31 |
| 2025-10-31 | 27,054 | 58,698 | -31,644 | 1.06 |
| 2025-10-15 | 58,698 | 43,523 | +15,175 | 1.00 |
| 2025-09-30 | 43,523 | 58,692 | -15,169 | 3.27 |
| 2025-09-15 | 58,692 | 68,937 | -10,245 | 5.59 |
| 2025-08-29 | 68,937 | 83,366 | -14,429 | 5.85 |
| 2025-08-15 | 83,366 | 114,399 | -31,033 | 3.58 |
| 2025-07-31 | 114,399 | 54,458 | +59,941 | 1.00 |
| 2025-07-15 | 54,458 | 70,633 | -16,175 | 2.25 |
| 2025-06-30 | 70,633 | 91,638 | -21,005 | 2.73 |
Showing 1–23 of 23 settlements